Dr. Plevy has served as Synlogic’s chief scientific officer since April 2019 and has responsibility for Synlogic’s research organization. Dr. Plevy most recently served as Vice President, Gastroenterology Disease Area Leader and IL-23 Pathway Leader at Janssen Research & Development, LLC, after a successful career in academia. He has served as the lead investigator on multiple early-phase clinical trials, published over 100 referenced papers and articles on a breadth of topics from disease-specific targets to basic immunology and molecular biology, and performed translational research to advance the understanding of novel immunologic interventions in inflammatory bowel disease, other inflammatory conditions, and microbiome-related diseases. He earned an M.D. and an A.B. in mathematics from Columbia University and carried out his residency training in internal medicine at Brigham and Women’s Hospital in Boston.